top of page

The Centre for Innovative Medical Research (CIMR) has been established to accelerate international collaboration for ideation, research, development, and commercialisation of scientific breakthroughs for the benefit of humankind.


CIMR was born out of a need created by the status quo of contemporary medical research.


While science and technology have never been more innovative and successful in the history of humankind, there are still numerous key medical and environmental health problems that remain unsolved. 

Impediments to solving these problems arise from:

  • Highly bureaucratic and lengthy research funding process

  • Difficulty funding truly creative ideas outside of the accepted scientific dogma

  • Outdated ‘fear of failure’ culture in Australia

  • Divide between academia and industry

  • Pressure for young scientists to compete for few tenured positions - leading to research solely geared to publishing large quantities of

  • Long ‘time to market’ process that can often lead to the loss of golden opportunities

  • Current academic reward system penalises industry collaboration, with the focus solely being on publications and citations.

To overcome these inhibitors, CIMR has been formed to accelerate the number of successful scientific outcomes for the benefit of humankind.

{Click for more information}

MW photo.jpg

Professor Michael Wallach

Co-Founder and Chief Executive Officer

BSc (U-M), MSc (HU), PhD (HU)

Professor Wallach has over 25 years of experience in basic and applied molecular parasitology with a background in both academic and industrial science.

+61 (0) 438 486 160

AnthonyHollis Headshot.png

Anthony Hollis

Co-Founder and Chief Operating Officer

Ba LLB University of Cape Town


Law degrees from Hebrew University and University of Sydney.  Admitted as Barrister at Law.

Anthony Hollis has over 40 years’ experience as a senior executive across a broad range of diverse and challenging roles including business strategy, managing high-performance teams, running businesses, sales, innovation, fund raising, investment and advisory.​

+61 (0) 412 009 333

bottom of page